Table 5.

Therapeutic evaluation of breast cancer.

Parameters	EG, n = 194	CG, n = 181	χ2 values	P-values
CR, n (%)	18(9.3)	6(3.3)	5.431	0.020∗
PR, n (%)	125(64.4)	78(43.1)	17.173	0∗
SD, n (%)	31(16)	45(24.9)	4.572	0.033∗
PD, n (%)	3(1.5)	14(7.7)	8.286	0.004∗
pCR, n (%)	61(31.4)	33(18.2)	9.223	0.002∗
HR+/HER2−	15(7.7)	11(6.1)	0.397	0.528
HR−/HER2+	8(4.1)	5(2.8)	0.519	0.471
HR+/HER2+	7(3.6)	4(2.2)	0.643	0.423
HR−/HER2−	21(10.8)	12(6.6)	2.053	0.152

^∗P < 0.05 vs. the CG group.